Funding for this research was provided by:
Deutsches Zentrum für Neurodegenerative Erkrankungen
BMBF (01-KU1216F, 01GNO813, 01ZX1314A)
Received: 31 August 2017
Accepted: 4 January 2018
First Online: 29 January 2018
Ethics approval and consent to participate
: Approval for the derivation of pluripotent cell lines for disease and therapeutic research. Ethikkommission, Medizinische Fakultät Bonn, Universität Bonn, serial no. 275/08.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.